{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:08:24Z","timestamp":1773421704260,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.amjms.2025.07.018","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:25:46Z","timestamp":1759335946000},"page":"305-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between depression and chronic liver disease: Potential role of antidepressants in modulating liver fibrosis"],"prefix":"10.1016","volume":"371","author":[{"given":"Ahmad Basil","family":"Nasir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Zouridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Aspichueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Manka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing-kin","family":"Syn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amjms.2025.07.018_bib0001","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v11i9.4408","article-title":"Gene-by-environment interaction in non-alcoholic fatty liver disease and depression: the role of hepatic transaminases","volume":"11","author":"Manusov","year":"2023","journal-title":"Med Res Arch"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.018_bib0002","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/aip.aip_46_19","article-title":"Depression and anxiety in patients with chronic liver disease and their relationship with quality of life","volume":"4","author":"Banerjee","year":"2020","journal-title":"Annals of Indian Psychiatry"},{"key":"10.1016\/j.amjms.2025.07.018_bib0003","first-page":"8","article-title":"Is fatty liver associated with depression? A meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease","author":"Xiao","year":"2021","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.amjms.2025.07.018_bib0004","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/liv.12165","article-title":"Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease","volume":"33","author":"Youssef","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.amjms.2025.07.018_bib0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fnmol.2017.00134","article-title":"Depression and chronic liver diseases: are there shared underlying mechanisms?","volume":"10","author":"Huang","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"10.1016\/j.amjms.2025.07.018_bib0006","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/apt.15068","article-title":"Depression in cirrhosis - a prospective evaluation of the prevalence, predictors and development of a screening nomogram","volume":"49","author":"Buganza-Torio","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.018_bib0007","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14087","article-title":"Depression in nonalcoholic fatty liver disease and all-cause\/cause-specific mortality","volume":"54","author":"Kim","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"10.1016\/j.amjms.2025.07.018_bib0008","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/biomedicines8070229","article-title":"Depression and cognitive impairment\u2014Extrahepatic manifestations of NAFLD and NASH","volume":"8","author":"Colognesi","year":"2020","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.amjms.2025.07.018_bib0009","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/apt.13090","article-title":"Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens","volume":"41","author":"Younossi","year":"2015","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1016\/j.amjms.2025.07.018_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194839","article-title":"The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes","volume":"13","author":"Shaheen","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.amjms.2025.07.018_bib0011","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jhep.2007.01.036","article-title":"Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis","volume":"46","author":"van Os","year":"2007","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.amjms.2025.07.018_bib0012","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/apt.15068","article-title":"Depression in cirrhosis \u2013 a prospective evaluation of the prevalence, predictors and development of a screening nomogram","volume":"49","author":"Buganza-Torio","year":"2019","journal-title":"Alimentary Pharmacol & Therapeutics"},{"issue":"3","key":"10.1016\/j.amjms.2025.07.018_bib0013","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2013.10.035","article-title":"Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis","volume":"60","author":"Schramm","year":"2014","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.amjms.2025.07.018_bib0014","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.3390\/nu7085270","article-title":"Higher body iron is associated with greater depression symptoms among young adult men but not women: observational data from the daily life study","volume":"7","author":"Richardson","year":"2015","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.amjms.2025.07.018_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/2045125318759461","article-title":"Psychiatric manifestations in Wilson\u2019s disease: possibilities and difficulties for treatment","volume":"8","author":"Litwin","year":"2018","journal-title":"Ther Adv Psychopharmacol"},{"issue":"5","key":"10.1016\/j.amjms.2025.07.018_bib0016","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3999(00)00155-0","article-title":"Depression, fatigue, and functional disability in patients with chronic hepatitis C","volume":"49","author":"Dwight","year":"2000","journal-title":"J Psychosom Res"},{"issue":"2\u20133","key":"10.1016\/j.amjms.2025.07.018_bib0017","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2012.11.059","article-title":"The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample","volume":"148","author":"Pacek","year":"2013","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.amjms.2025.07.018_bib0018","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jgh.12897","article-title":"Non-alcoholic fatty liver disease comorbid with major depressive disorder: the pathological features and poor therapeutic efficacy","volume":"30","author":"Tomeno","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.amjms.2025.07.018_bib0019","first-page":"12","article-title":"Interaction mechanisms between major depressive disorder and non-alcoholic fatty liver disease","author":"Shao","year":"2021","journal-title":"Front Psychiatry"},{"issue":"10","key":"10.1016\/j.amjms.2025.07.018_bib0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","article-title":"Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis","volume":"26","author":"Grenard","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amjms.2025.07.018_bib0022","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.amjms.2025.07.018_bib0023","first-page":"11","article-title":"Influence of stress and depression on the immune system in patients evaluated in an anti-aging unit","author":"Ca\u00f1as-Gonz\u00e1lez","year":"2020","journal-title":"Front Psychol"},{"issue":"18","key":"10.1016\/j.amjms.2025.07.018_bib0024","doi-asserted-by":"crossref","first-page":"30464","DOI":"10.18632\/oncotarget.12826","article-title":"Hepatocellular carcinoma and antidepressants: a nationwide population-based study","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.amjms.2025.07.018_bib0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","article-title":"Antidepressant-induced liver injury: a review for clinicians","volume":"171","author":"Voican","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.amjms.2025.07.018_bib0026","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1152\/ajpendo.00181.2019","article-title":"Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism","volume":"318","author":"Lu","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.amjms.2025.07.018_bib0027","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1210\/er.2018-00283","article-title":"Emerging roles for serotonin in regulating metabolism: new implications for an ancient molecule","volume":"40","author":"Yabut","year":"2019","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.amjms.2025.07.018_bib0028","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/jvh.12884","article-title":"Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: results from ERCHIVES","volume":"25","author":"Chen","year":"2018","journal-title":"J Viral Hepat"},{"issue":"12","key":"10.1016\/j.amjms.2025.07.018_bib0029","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s40262-014-0187-5","article-title":"Pharmacokinetics of antidepressants in patients with hepatic impairment","volume":"53","author":"Mauri","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.amjms.2025.07.018_bib0030","series-title":"Liver Injury Associated With Antidepressants","first-page":"207","author":"Park","year":"2013"},{"issue":"2","key":"10.1016\/j.amjms.2025.07.018_bib0031","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1152\/ajpendo.00181.2019","article-title":"Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism","volume":"318","author":"Lu","year":"2020","journal-title":"Am J Physiol-Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.018_bib0032","first-page":"1","article-title":"Gut liver brain axis in diseases: the implications for therapeutic interventions. Article","volume":"8","author":"Mengyao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.amjms.2025.07.018_bib0033","first-page":"12","article-title":"The gut-liver axis in health and disease: the role of gut microbiota-derived signals in liver injury and regeneration","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.amjms.2025.07.018_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101390","article-title":"Antidepressants in people with chronic liver disease and depression: when are they warranted and how to choose the suitable one?","volume":"14","author":"Sahoo","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.amjms.2025.07.018_bib0035","first-page":"15","article-title":"Causal relationship between depression and metabolic dysfunction-associated steatotic liver disease: a bidirectional mendelian randomized study","author":"Liang","year":"2024","journal-title":"Front Psychiatry"},{"issue":"2","key":"10.1016\/j.amjms.2025.07.018_bib0036","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3390\/ijms24021703","article-title":"GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives","volume":"24","author":"Nevola","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjms.2025.07.018_bib0037","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpsychires.2023.05.041","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review","volume":"164","author":"Cooper","year":"2023","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.amjms.2025.07.018_bib0038","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1016\/j.apsb.2022.06.003","article-title":"The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-therapeutic potential exploration in lung injury","volume":"12","author":"Pang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.amjms.2025.07.018_bib0039","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221108064","article-title":"Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review","volume":"13","author":"Deng","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.amjms.2025.07.018_bib0040","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1017\/S204579602000116X","article-title":"Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity","volume":"30","author":"Cho","year":"2021","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.amjms.2025.07.018_bib0041","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jad.2023.02.101","article-title":"Association between depression and metabolic dysfunction-associated fatty liver disease\/significant fibrosis","volume":"329","author":"Kim","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.amjms.2025.07.018_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106577","article-title":"Fluvoxamine alleviates bleomycin-induced lung fibrosis via regulating the cGAS-STING pathway","volume":"187","author":"Xie","year":"2023","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.amjms.2025.07.018_bib0043","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ki.2008.578","article-title":"Amitriptyline attenuates interstitial inflammation and ameliorates the progression of renal fibrosis","volume":"75","author":"Achar","year":"2009","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.amjms.2025.07.018_bib0044","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/hepr.12352","article-title":"Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice","volume":"45","author":"Quillin","year":"2015","journal-title":"Hepatology Res"},{"issue":"2","key":"10.1016\/j.amjms.2025.07.018_bib0045","first-page":"62","article-title":"Cardiac and renal fibrosis, the silent killer in the cardiovascular continuum: an up-to-date","volume":"11","author":"Chiuariu","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.amjms.2025.07.018_bib0046","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2021.12.128","article-title":"Association between nonalcoholic fatty liver disease and depression: a systematic review and meta-analysis of observational studies","volume":"301","author":"Gu","year":"2022","journal-title":"J Affect Disord"},{"issue":"7","key":"10.1016\/j.amjms.2025.07.018_bib0047","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/jvh.12884","article-title":"Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: results from <scp>ERCHIVES<\/scp>","volume":"25","author":"Chen","year":"2018","journal-title":"J Viral Hepat"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:19:33Z","timestamp":1773418773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925012145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0002962925012145"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.07.018","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between depression and chronic liver disease: Potential role of antidepressants in modulating liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}